Author Archives: ev1

Millan is proof that Positive Reinforcement Works …

Posted on by

Millans methods are a result of positive reinforcement. Not the dogs they are not reinforced, they are almost always punished. It is Millan that has been positively reinforced.

Once upon a time Millan met a dogs aggressive behavior with aggression. He managed to stop the behavior and thus was rewarded for his aggression. He was positively reinforced. It provided quick control, required no training an allowed him to deal with one dog and quickly moved to another; an assembly line of fear and punishment. Dealing with dogs like they were parts to be hammered into the desired shape; quiet and lacking any behavior. What he calls calm and submissive

From the first time that he was able to shut down a dog through the use of violence, he has been continually reinforced. For Millan punishing dogs was reinforcing. Dealing pain, fear and shutting down dogs was profitable, it earned him the admiration of his employers and the clients. There was no downside.

As his fame increased so did the value of the reinforcement. A television program, celebrity friends, books, travel, popular admiration, fame and wealth; the world rewarded him for using archaic and violent methods.

Many would be doing the same, even if they knew there was a better way. Changing his ways may lose him that fame. Change or the possibility of change comes with uncertainty, anxiety. In other words, it is punishing.

Cesar Millan has been using violence for long that his behavior is now a well ingrained habit. Very much like a positively trained dog. Or like the dogs he deals with whove been reinforced for unwanted behavior.

So, does positive reinforcement work? It worked on Cesar Millan.

Hes been reinforced for aggressive antisocial behavior and he needs re-training. He better hope that HIS trainer doesnt subscribe to His philosophies or the retraining might kill him.

Like Loading...

. Tags:

More here:
Millan is proof that Positive Reinforcement Works ...

York College students say goodbye to students, faculty and campus life

Posted on by

Heather Dachiu planned to celebrate her graduation from York College in the most York countian way she could think of: by having lunch at Round the Clock Diner.

Dachiu was among nearly 300 students who accepted their diplomas Wednesday as the December 2014 graduating class. Armed with her bachelor of science in early childhood and special education, Dachiu was sad to leave behind the life she'd built on campus.

"I've been replaying my whole college experience all day," she said, waiting to enter the Grumbacher Sports and Fitness Center to say goodbye to classmates, faculty and the York College campus.

Katherine Agostini, who received her bachelor of science in behavioral sciences, had 14 family members waiting to watch her walk across the stage to accept her diploma.

"It sounds silly, but I'm really going to miss the faculty," she said. "Each one made it possible for me to even be here today."

The ceremony was filled with tearful goodbyes and triumphant dances as students recalled the past four or more years they spent at the college.

Student speaker, Anastasia Moore, who received her bachelor of arts in public relations, delivered a humorous speech that told the story of her interactions with her York College family.

She remembered the first time she was introduced to campus life, on a hot August day when her parents packed the car with items she said she would never use.

When they kissed her goodbye, Moore was given advice that only a mother can provide: "Don't come home stupid."

The next four years of her college education would be filled with weekends at Yorktown Pizzeria, a staple of the York College student diet. The establishment closed, leaving empty stomachs and fond memories behind, Moore said.

Originally posted here:
York College students say goodbye to students, faculty and campus life

Leading Southern Ohio Endocrinologist Dr. Jane Cases Launches A Revolutionary Skin And Hair Loss Product Line

Posted on by

Marietta, Ohio (PRWEB) December 17, 2014

Leading Southern Ohio endocrinologist Dr. Jane Cases today announced the launch of the Healing Saint product line, which consists of two products that enhance the ability of the skin and scalp to repair and renew itself. The Healing Saint Luminosity Skin Serum reduces the appearance of fine lines, fades age spots, minimizes uneven tone, reduces adult acne and increases luminosity and The Healing Saint Medicated Scalp Serum results in a revitalized scalp with thickened hair roots, reduced hair loss and decreased premature breakage.

The Healing Saint product line contains no Endocrine Disrupting Chemicals (EDCs). Scientific studies of animals and humans support a link between EDCs and harm to human health such as infant brain development, childhood obesity, thyroid dysfunction, diabetes, some cancers and more.

Dr. Cases, who is board certified in endocrinology and diplomate in anti-aging and regenerative medicine, with special interest in cell therapy, has worked for years with people suffering from hair loss or Alopecia and personally experienced a severe road bike accident that left her with scars on her face and arm. Dr. Cases could not find an effective solution for her patients or herself after her accident, and so she spent the next several years developing the Healing Saint product line, ensuring that both products work with the skins natural processes.

Our products aim to replace what have been lost due to aging or other health related issues and replenish the scalp or skin with essential growth factors, proteins and cytokines. And, since they contain no EDCs, which are mostly man made, there is no mimicking, interfering or blocking of the normal functioning of our bodys natural hormones, said Dr. Cases. The early user results for the Healing Saint product line have been extremely positive, and we are looking forward to helping many more individuals eliminate frustration with hair loss and/or skin problems and gain back their self-esteem.

The name Healing Saint comes from inspiration from the healer and saint Agnes who, while maintaining faith during suffering, grew her hair.

For early testimonials on Healing Saint, click here: http://www.healingsaint.com/p/testimonials.html. To learn more about the Healing Saint product line, visit http://www.healingsaint.com.

About Jane Cases, MD. Dr. Cases, board certified in endocrinology and a diplomate in anti-aging and regenerative medicine, serves as a leading medical provider in southern Ohio. Her work focuses on endocrinology, diabetes, and metabolism as well as stem cell therapy, platelet-rich plasma (PRP) therapy, aesthetics and much more. Her passion for total wellness and weight management led her to start Wellness 360 Comprehensive Lifestyle Center in Marietta, Ohio, where she serves as Chief Medical Officer. The development of The Healing Saint comes from her passion for regenerative medicine to help patients who want to fully address or prevent lifestyle diseases.

A graduate of Montefiore Medical Center in New York, Dr. Cases also serves as a speaker and a member of the advisory board for pharmaceutical companies on diabetes drugs in North America. Additionally, she holds active professional memberships with American Board of Internal Medicine, Endocrine Society, USA, American Thyroid Association, American Association of Clinical Endocrinologists, European Association for the Study of Diabetes, and American Academy of Anti-aging Medicine.

About the Healing Saint Launched in 2014, the Healing Saint product line aims to replace what have been lost due to aging or other health related issues and replenish the scalp or skin with essential growth factors, proteins and cytokines. The Healing Saint product line contains no Endocrine Disrupting Chemicals (EDCs). Scientific studies of animals and humans support a link between EDCs and harm to human health such as infant brain development, childhood obesity, thyroid dysfunction, diabetes, some cancers, decreased fertility, and low testosterone in men, women and children. For more information, visit http://www.healingsaint.com.

Link:
Leading Southern Ohio Endocrinologist Dr. Jane Cases Launches A Revolutionary Skin And Hair Loss Product Line

"The biggest small step." Eric Betzig, 2014 Nobel Prize in Chemistry laureate, on breakthroughs – Video

Posted on by


"The biggest small step." Eric Betzig, 2014 Nobel Prize in Chemistry laureate, on breakthroughs
Eric Betzig, 2014 Nobel Prize in Chemistry laureate, was interviewed on 6 December, 2014 at the Nobel Museum in Stockholm, Sweden. The Nobel Prize in Chemistry 2014 was awarded jointly to...

By: Nobel Prize

Continued here:
"The biggest small step." Eric Betzig, 2014 Nobel Prize in Chemistry laureate, on breakthroughs - Video

The difference between academia and industry according to Eric Betzig, 2014 Nobel Chemistry Laureate – Video

Posted on by


The difference between academia and industry according to Eric Betzig, 2014 Nobel Chemistry Laureate
Eric Betzig, 2014 Nobel Prize in Chemistry laureate, was interviewed on 6 December, 2014 at the Nobel Museum in Stockholm, Sweden. The Nobel Prize in Chemistry 2014 was awarded jointly to...

By: Nobel Prize

Visit link:
The difference between academia and industry according to Eric Betzig, 2014 Nobel Chemistry Laureate - Video

Alnylam Provides Pipeline Update, Growth Strategy – Analyst Blog

Posted on by

Alnylam Pharmaceuticals, Inc. ( ALNY ) announced its pipeline growth strategy for the development and commercialization of RNAi therapeutics across three strategic therapeutic areas (STArs) - genetic medicines, cardio-metabolic disease and hepatic infectious disease.

Alnylam's genetic medicine STAr consists of a broad pipeline of RNAi therapeutics including patisiran (phase III - APOLLO) and revusiran (phase III - ENDEAVOUR), being developed for the treatment of transthyretin-mediated amyloidosis. Additionally, the company reported positive initial data from a phase I study on ALN-AT3 last week.

The company is advancing ALN-AT3 for the treatment of hemophilia and rare bleeding disorders. Further, the company plans to initiate a phase I/II study on ALN-CC5 for paroxysmal nocturnal hemoglobinuria.

Meanwhile, Alnylam intends to commercialize its genetic medicine products in the U.S. and EU, while Genzyme, a Sanofi ( SNY ) company, will develop and commercialize in the rest of the world.

In its cardio-metabolic disease STAr, Alnylam recently initiated a phase I study on ALN-PCSsc (RNAi therapeutic targeting PCSK9 for the treatment of hypercholesterolemia) with initial data expected in mid-2015. Alnylam has an agreement with The Medicines Company ( MDCO ) for ALN-PCSsc. Alnylam is also advancing other candidates including ALN-AC3 (hypertriglyceridemia), ALN-ANG (hypertriglyceridemia and mixed hyperlipidemia) and ALN-AGT (hypertensive disorders of pregnancy including preeclampsia) among others.

Finally, Alnylam's hepatic infectious disease STAr includes ALN-HBV for the treatment of hepatitis B viral infection. The company intends to file an investigational new drug (IND) application or an IND equivalent in late 2015.

Alnylam is looking for partnerships for programs in its cardio-metabolic disease and hepatic infectious disease STArs. At the same time it intends to retain significant product commercialization rights in the U.S. and EU.

Alnylam expects to provide additional guidance on pipeline programs in its three STArs in Jan 2015. We expect investor focus to remain on Alnylam's pipeline.

Alnylam currently carries a Zacks Rank #2 (Buy). A better-ranked stock in the health care sector is Amgen Inc. ( AMGN ) carrying a Zacks Rank #1 (Strong Buy).

ALNYLAM PHARMA (ALNY): Free Stock Analysis Report

Continue reading here:
Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog

MU scientist and inventor advances the study of nanomedicine

Posted on by

PUBLIC RELEASE DATE:

16-Dec-2014

Contact: Jeff Sossamon sossamonj@missouri.edu 573-882-3346 University of Missouri-Columbia @mizzounews

COLUMBIA, Mo. - Nanomedicine is the medical application of nanotechnology, or the use of microscopic structures to diagnose, image, treat and prevent disease. Current problems in nanomedicine include understanding and anticipating the potentially toxic impact these nanostructures have on the body and the environment once they're released. Kattesh Katti, a researcher at the University of Missouri, is developing nano-scale molecules, including gold nanoparticles and other "green" technologies, to image and treat diseases such as cancer, Parkinson's disease, arthritis and degeneration of the eye--all while curtailing the impact these structures sometimes have on the body and environment.

For distinguished contributions to the fields of chemistry, radiopharmaceutical sciences, green nanotechnology and nanomedicine, Katti has been chosen for induction as a Fellow of the National Academy of Inventors (NAI). Election as an NAI Fellow is a high professional distinction accorded to academic inventors who have demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.

"I am thrilled to be elected into this prestigious fellowship of the National Academy of Inventors," Katti said. "It is particularly gratifying that I am joining the august group of outstanding NAI fellows along with another great Mizzou colleague who is also being inducted. Election into NAI is a clear reflection of our outstanding quality of discovery research here at MU as our academic approach is embedded with inventions and entrepreneurship. I am indebted to all my teachers, collaborators, post-doctoral fellows and students because this success is a culmination of our collective painstaking efforts. I thank my wife Kavita, our children and my parents for all their support throughout my professional life."

Katti, Curators Professor of Radiology and Physics in the School of Medicine and the College of Arts and Science and senior research scientist at the University of Missouri Research Reactor (MURR), pioneered the development of several nanomedicine tools used in hospitals worldwide. Cancer specialists treating prostate cancer with gold nanoparticles, for instance, often were limited to using high doses of toxic chemotherapy. Katti and other researchers at MU found a more efficient way of targeting prostate tumors by using gold nanoparticles and a compound found in tea leaves. When combined through methods he developed, this treatment can be used in much smaller doses and travels through the body without inflicting damage to healthy areas.

Katti's work in developing green nanotechnology includes the use of common spices and plants to target, image and treat ailments. The usual method of creating gold nanoparticles utilizes harmful chemicals and acids that are not environmentally safe and contain toxic impurities. Katti helped develop the method that scientists use to mix gold salts with cinnamon and stir the mixture with water to synthesize gold nanoparticles. These green therapies are less toxic to the body and could provide alternatives to current treatments like chemotherapy and radiation which have negative side effects.

"As a professor of journalism, I can see how Kattesh's inventions will reach both our students and society at large," said Randall D. Smith, professor and Donald W. Reynolds Endowed Chair of Business Journalism in the Reynolds Journalism Institute at MU. "His approach to academic enterprise stands as a role model on how academicians, regardless of their discipline, should embrace inventions and entrepreneurial philosophy in teaching and research."

Katti holds a doctorate in inorganic chemistry from the Indian Institute of Science. He was selected as "One of 25 Most Influential Scientists in Molecular Imaging in the World" by rt Image in recognition of his pioneering work on the utility of gold nanoparticles in imaging and therapy. Nobel Laureate Norman Borlaug cited Katti as the "Father of Green Nanotechnology" in recognition of his groundbreaking green nanotechnology invention of producing gold nanoparticles by simple mixing of soy beans with gold salt. Katti was inducted as a Fellow of the American Association for the Advancement of Science (AAAS) and is a Fellow of the St. Louis Academy of Science. His green nanotechnology discovery using cinnamon-phytochemicals in the mediated production of gold nanoparticles was selected as "one of the 10 best inventions of 2010" by BioresearchOnline.com.

Read this article:
MU scientist and inventor advances the study of nanomedicine

National Academy of Inventors Names Two Sanford-Burnham Researchers as Charter Fellows

Posted on by

Contact Information

Available for logged-in reporters only

Newswise La Jolla, Calif., December 16, 2014 Two professors at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have been named Charter Fellows of the National Academy of Inventors (NAI): Erkki Ruoslahti, M.D., Ph.D., distinguished professor and former president of Sanford-Burnham, and Kristiina Vuori, M.D., Ph.D., current president of the Institute. Ruoslahti and Vuori are now part of a group of 414 NAI Fellows from more than 150 prestigious research universities, government, and nonprofit research institutions.

Election to the NAI Fellows is a significant professional distinction accorded to academic inventors who have demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.

Im honored to be named a Charter Fellow of the NAI, said Vuori. I owe a large part of this distinction to the talented scientists, staff, and students I have worked with at Sanford-Burnham over the years.

Academic inventors are elected by their peers for innovative contributions in areas such as patenting and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation.

An internationally recognized leader in nanomedicine, Ruoslahti focuses his research on directing drugs to sites of disease. His main discovery and invention is the integrin-binding tripeptide motif RGD, a sequence within fibronectin that mediates cell attachment, and is found in numerous other cell-attachment proteins. His recent work has contributed to better tumor imaging and improving drug delivery to specific disease sites.

It is a great honor to be named a Fellow of the NAI, said Ruoslahti. There are so many giants of innovation that have received this distinction, and Im grateful to be part of that group.

Ruoslahti holds 314 issued patents, and is the founder of the Center for Nanomedicine at UC Santa Barbara, a member of the U.S. National Academy of Sciences and the Institute for Medicine, and a member of the Academy of Arts and Sciences. He is the recipient of the Japan Prize, Gairdner Award, Clowes Award, Pasarow Award, and Jacobaeus Prize, and is a 2012 Thomson Reuters Citation Laureate. He is Knight and Commander of the Orders of the White Rose of Finland and the Lion of Finland.

Vuori joined the faculty of Sanford-Burnham in 1996 and has been president of Sanford-Burnham since 2010. She is also professor and holder of the Pauline and Stanley Presidential Chair, and served as director of Sanford-Burnhams NCI-designated Cancer Center from 2005 until 2013. Her main research focus is aimed at unraveling the molecular mechanisms of cancer metastasis, particularly the process that makes normal cells adhesion dependent. Normal cells adhere to their microenvironment for survival; if they become detached they will die. Cancer cells are somehow able to detach from their surroundings and move to other tissues in the body and survive and grow. Understanding the mechanisms of cell adhesion opens new approaches to preventing cancer metastasis.

See more here:
National Academy of Inventors Names Two Sanford-Burnham Researchers as Charter Fellows

The Future Internet Market In 2025 Available online By Market Research Reports.Biz

Posted on by

Albany, NY (PRWEB) December 16, 2014

This report presents a detailed perspective of potential futures for the Internet services market by 2025, with their impacts on the adjacent ICT market of devices, telecom and software and on non-ICT, vertical markets.

View Full Report at http://www.marketresearchreports.biz/analysis/235575

By using assumptions regarding openness of ecosystems and personal data, it assesses the major disruptive trends around technology, usage, business models and regulations, to determine the greatest uncertainties that will shape perceptions in 2025. Four major scenarios platform wars, low-cost islands, open innovation and 'pay per trust' are identified and quantified, with breakdowns by business model (advertising, one-off payment, unlimited subscriptions and commission on sales) and by service (cloud, video, social, search, mobile, e-commerce, communications, RTB and digital content).

Downlaod Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/235575

3. The fundamental disruptions induced by Internet development 3.1. Drivers 3.1.1. The rollout of standardised and open technologies 3.1.2. The economics of information 3.1.3. Network agnosticism 3.1.4. Reach 3.2. Barriers 3.2.1. Proprietary technologies 3.2.2. Cost structure of non-software-based services 3.2.3. Network interoperability and access 3.2.4. Local and commercial barriers 3.3. Overall impacts for service provider activities 3.3.1. Service Development: Lower cost per unit 3.3.2. Evolution of the ecosystem: New value chains? 3.3.3. New market environment

4. Technologies 4.1. Key technologies 4.1.1. Network infrastructure and standards: Fibre, LTE, QoS, SDN 4.1.2. Traffic management and optimisation solutions: CDN, DPI/PCRF, small cells 4.1.3. Cloud infrastructure and data management: The cloud and big data 4.1.4. Internet of Things: M2M, RFID, wearables, sensors 4.1.5. Mobile technologies: GPS, NFC, QR code and augmented reality 4.1.6. Security 4.2. Analysis of technology trends 4.2.1. Main disruptive technologies 4.2.2. Other disruptive technologies 4.2.3. Other technologies 4.3. Conclusions and uncertainties

Explore All Idate Market Research Reports at http://www.marketresearchreports.biz/publisher/91

Table 1: Mobile network performance levels Table 2: Status of regulatory debates and policies, by country, in 2014 Table 3: Various graduated response measures o piracy implemented by in some countries Table 4: Key uncertainties presented in previous sections Table 5: Characteristics and impacts of uncertainties in Platform Wars scenario Table 6: Characteristics and impacts of uncertainties in Open Innovation scenario Table 7: Characteristics and impacts of uncertainties in Low-cost Islands scenario Table 8: Characteristics and impacts of uncertainties in Pay per Trust scenario Table 9: Internet markets, 2013-2018 & 2025 - Platform Wars scenario Table 10: Focus on major Internet markets, 2013-2018 & 2025 - Platform Wars scenario Table 11: Breakdown of Internet market by business model, 2013-2018 & 2025 - Platform Wars scenario Table 12: Internet markets, 2013-2018 & 2025 - 10.2. Low-cost Islands scenario Table 13: Focus on major Internet markets, 2013-2018 & 2025 - Low-cost Islands scenario Table 14: Breakdown of Internet market by business model, 2013-2018 & 2025 - Low-cost Islands scenario Table 15: Internet markets, 2013-2018 & 2025 Open Innovation scenario Table 16: Focus on major Internet markets, 2013-2018 & 2025 - Open Innovation scenario Table 17: Breakdown of Internet market by business model, 2013-2018 & 2025 - Open Innovation scenario Table 18: Internet markets, 2013-2018 & 2025 Pay per Trust scenario Table 19: Focus on major Internet markets, 2013-2018 & 2025 - Pay per Trust scenario Table 20: Breakdown of Internet market by business model, 2013-2018 & 2025 - Pay per Trust scenario About Us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Continued here:
The Future Internet Market In 2025 Available online By Market Research Reports.Biz

New colorectal cancer risk factor identified

Posted on by

PUBLIC RELEASE DATE:

15-Dec-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline

New Rochelle, NY, December 15, 2014-Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Genetic Testing and Molecular Biomarkers website until January 11, 2014.

Xin Guo, First Affiliated Hospital of Harbin Medical University, China, and Jiaqi Liu, Liuping You, Gang Li, Yuenan Huang, and Yunlong Li, Second Affiliated Hospital of Harbin Medical University, explored the relationship between two polymorphisms in the adiponectin gene and the risk of colorectal cancer in the article "Association Between Adiponectin Polymorphisms and the Risk of Colorectal Cancer." They also showed that these genetic variations may interact with environmental factors, such as red meat intake, to affect cancer risk.

"This paper suggests that adiponectin gene sequence may have significant prognostic value for colorectal cancer," says Kenneth I. Berns, MD, PhD, Editor-in-Chief of Genetic Testing and Molecular Biomarkers, and Director of the University of Florida's Genetics Institute, College of Medicine, Gainesville, FL.

###

About the Journal

Genetic Testing and Molecular Biomarkers is an authoritative peer-reviewed journal published monthly online with Open Access options and in print that reports on all aspects of genetic testing, including molecular and biochemical based tests and varied clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling. Genetic Testing and Molecular Biomarkers is the official journal of Genetic Alliance. Complete tables of content and a free sample issue may be viewed on the Genetic Testing and Molecular Biomarkers website.

About the Publisher

See the rest here:
New colorectal cancer risk factor identified

Do caffeine’s effects differ with or without sugar?

Posted on by

PUBLIC RELEASE DATE:

16-Dec-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline

New Rochelle, NY, December 16, 2014-Consuming caffeinated or sugary drinks can affect the body's metabolism, causing changes in heart and respiratory rate and weight gain. The results of a new study exploring whether individuals respond differently to caffeinated drinks that do or do not contain sugar and to sugar alone are published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Caffeine Research website at http://online.liebertpub.com/doi/full/10.1089/jcr.2014.0023 until January 16, 2015.

The article entitled "Caffeine With and Without Sugar: Individual Differences in Physiological Responses During Rest", by Elaine Rush, PhD and coauthors, Auckland University of Technology (Auckland, New Zealand), describes a study in which heart rate and carbon dioxide production (as a measure of respiration) were measured 30 minutes before and after individuals consumed a defined quantity of sugar, caffeine, or sugar and caffeine. Responses to the different treatments varied widely among individuals.

"Given the caveat that sugar itself affects brain reward just as caffeine does, and this effect will in itself cause variations, this is still an essential paper for the scientist and the lay person to read," says Patricia A. Broderick, PhD, Editor-in-Chief of Journal of Caffeine Research, Medical Professor in Physiology, Pharmacology & Neuroscience, The Sophie Davis School of Biomedical Education, The City College of New York, The City University of New York, and Adjunct Professor in Neurology, New York University Langone Medical Center and Comprehensive Epilepsy Center.

###

About the Journal

Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science is a quarterly journal published in print and online. The Journal covers the effects of caffeine on a wide range of diseases and conditions, including mood disorders, neurological disorders, cognitive performance, cardiovascular disease, and sports performance. Journal of Caffeine Research explores all aspects of caffeine science including the biochemistry of caffeine; its actions on the human body; benefits, dangers, and contraindications; and caffeine addiction and withdrawal, across all stages of the human life span from prenatal exposure to end-of-life. Tables of content and a sample issue may be viewed on the Journal of Caffeine Research website at http://www.liebertpub.com/jcr.

About the Publisher

Read the rest here:
Do caffeine's effects differ with or without sugar?

Day in the Life of a Food Science Student

Posted on by

Contact Information

Available for logged-in reporters only

Newswise CHICAGOThe Institute of Food Technologists (IFT) is proud to introduce a new video in the Day in the Life of a Food Scientist series that shows what its like to be a food science student. Featured in the video are Amy DeJong and Maya Warren, PhD students in the Food Science Department at the University of Wisconsin-Madison. In addition to being lab mates, DeJong and Warren are also one of the final four teams competing in the CBS television reality series, The Amazing Race.

We wanted to show how scientists are so much more than lab coats, beakers and goggles, said DeJong about why they wanted to try out for the show. The Amazing Race is an Emmy Award-winning reality series that pits 11 teams, each comprised of two members, against each other on a trek around the world where teams compete in a series of mental and physical challenges. DeJong and Warren beat out seven other teams to make it to the final leg which airs on CBS Friday, December 19th at 8/7c.

The IFT video follows DeJong and Warren on campus as they study, work in the lab, and interact with faculty and students. DeJong is studying polyol (sugar-free sweetener) crystallization in confectionery products.Warrens area of research focuses on the microstructural, behavioral, and sensorial properties of ice cream and other frozen-aerated treats.

Both DeJong and Warren hope that the IFT video and their involvement in the Amazing Race will show people that scientists are high-energy people who step outside of the lab often to work with a variety of different people and cultures.

The Day in the Life of a Food Scientist videos are designed to educate students, teachers, media, and the general public about the positive impact and rewards of the food science and technology profession. Additional videos include: Day in the Life of a Food Scientist at NASA, Day in the Life of a Food Scientist at Disney Consumer Products, Day in the Life of a Food Packaging Professional, Day in the Life of a Food Science Professor, and Day in the Life of an FDA Food Scientist.

IFT has more information on this exciting career at Become a Food Scientist.

About IFT This year marks the 75th anniversary of the Institute of Food Technologists. Since its founding in 1939, IFT has been committed to advancing the science of food. Our non-profit scientific societymore than 18,000 members from more than 100 countriesbrings together food scientists, technologists and related professionals from academia, government and industry. For more information, please visit ift.org.

View original post here:
Day in the Life of a Food Science Student